Monsanto Corporation has been granted exclusive monopoly over all genetically transformed soyabean varieties. The Munich-based European Patent Office (epo) upheld a patent held by Monsanto on transgenic research on soyabean.
The patent covers the process that describes genetic transformation of plants and soyabean seeds as well as tissues obtained by such processes. The epo, however, rejected the company's demands to extend the scope of the patent to all plants. Interestingly, Monsanto had vigorously opposed the patent until it bought Agracetus -- the original patent holder -- in 1996. Suman Sahai, president of India's Delhi-based Gene Campaign, feels the patent should not have been upheld because the genetic modification process described for soyabean was insufficient to allow anyone from the same discipline to replicate the procedure -- a basic prerequisite.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.